SC

Sajeev Chellappan Janaki

Active Director Director DIN 02674475
DIN 02674475 First appointment Jun 2009 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Sajeev Chellappan Janaki

Data last updated:

Sajeev Chellappan Janaki is a Director at Sajeev's Indian Systems Of Medicines And Food Products Private Limited (since 2009). The company operates in Chemicals.

DIN 02674475
Primary Designation Director
Industry Chemicals
First Appointment 19 Jun 2009
Oldest Company Age 17 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jun 20092009Active

Board colleagues of Sajeev Chellappan Janaki

Directorship timeline

Open interactive timeline →
Sajeev's Indian Systems Of Medicines And Food Products Private Limited
Premium access

Shareholding and investment profile for Sajeev Chellappan Janaki

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sajeev Chellappan Janaki

Sajeev Chellappan Janaki currently holds 1 directorship: Sajeev's Indian Systems Of Medicines And Food Products Private Limited (Director, since 19 Jun 2009).

Sajeev Chellappan Janaki was first appointed on 19 Jun 2009 as Director at Sajeev's Indian Systems Of Medicines And Food Products Private Limited.

The current boards of Sajeev Chellappan Janaki's companies include Kiran Babu Vijayan (Sajeev's Indian Systems Of Medicines And Food Products Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available